Back to Trades
Reich Kristian
Chief Scientific OfficerCIK 0001920553
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 1
- Active
- 2025–2026
Across 7 filings between 2025–2026, Reich Kristian, Chief Scientific Officer, has disclosed $8.1M in transactions — all concentrated in MoonLake Immunotherapeutics (MLTX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $8.1M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 29 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Sell | $22.0K |
| Jul 23 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Sell | $1.0M |
| Jul 21 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Sell | $877.9K |
| Jul 20 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Sell | $322.3K |
| Jun 17 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Sell | $2.9M |
| Dec 10 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Sell | $3.0M |
| Sep 4 | MLTX MoonLake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | Conversion | $0 |
7 filings